PE20020844A1 - Derivados de imidazolilo como inhibidores del factor de liberacion de la corticotropina - Google Patents
Derivados de imidazolilo como inhibidores del factor de liberacion de la corticotropinaInfo
- Publication number
- PE20020844A1 PE20020844A1 PE2002000063A PE2002000063A PE20020844A1 PE 20020844 A1 PE20020844 A1 PE 20020844A1 PE 2002000063 A PE2002000063 A PE 2002000063A PE 2002000063 A PE2002000063 A PE 2002000063A PE 20020844 A1 PE20020844 A1 PE 20020844A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- link
- compounds
- release factor
- corticotropin
- Prior art date
Links
- -1 IMIDAZOLYL Chemical class 0.000 title abstract 5
- 102400000739 Corticotropin Human genes 0.000 title abstract 2
- 101800000414 Corticotropin Proteins 0.000 title abstract 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 title abstract 2
- 229960000258 corticotropin Drugs 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 101100439662 Arabidopsis thaliana CHR5 gene Proteins 0.000 abstract 2
- 101100439663 Arabidopsis thaliana CHR7 gene Proteins 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Nutrition Science (AREA)
Abstract
SE REFIERE A DERIVADOS DE IMIDAZOLILO DE FORMULA I DONDE R1 ES H, ALQUILO C1-C6, HALOALQUILO C1-C6, ENTRE OTROS; R2 ES C(D)NR3R4, D'-D"R3R4, CH2NR3R4; D' ES CH2, UN ENLACE; D" ES C, COH, CH; D ES O, S R3 Y R4 SON H, ALQUILO C1-C6, HALOALQUILO C1-C6, HIDROXIALQUILO C1-C6 O JUNTO A N FORMAN UN HETEROCICLO, ENTRE OTROS; X ES C, Y ES C; A S, UN GRUPO a; X1 ES N Y ESTA UNIDO A X; Y1 ES N, ESTA UNIDO A Y; G ES Y2=J=Z1; Y2 ES N, CH, CH2, CO, CS, CR5, CHR5, CE1; J ES CH, CH2, CO, CS, CR6, ENTRE OTROS; Z1 ES CH, CH2, CO, CS, CR7, CHR7, ENTRE OTROS; R5, R6, R7 SON CN, ALQUILEN C1-C4-CN, HALO, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; E1 Y E2 FORMAN JUNTOS CHN(CH)2, N(CH)2N, ENTRE OTROS; E2 Y Z2 JUNTOS FORMAN N(CH)3, HCN(CH2)2, ENTRE OTROS; Z ES N-V, V ES FENILO, 3-PIRIDILO, ENTRE OTROS; SI Y2 ES N, J ES UN ENLACE, Z1 NO ES CE3; SI Y2 ES CE1, Z1 ES CE3, J ES UN ENLACE; SI Y2 NO ES CE1, Z1 NO ES CE3, J NO ES CE2, J ES CE2; ENTONCES CE1 Y Z1 NO SON CE3, CR7, CHR7; Z1 ES CE2, Y2 NO ES CE1, CR5, CHR5; SON COMPUESTOS PREFERIDOS CICLOPROPILMETIL-(2,2,2-TRIFLUORO-ETIL)-[2-TRIFLUOROMETIL-8-(2,4,6-TRIMETIL-FENIL)-5,6,7,8-TETRAHIDROIMIDAZOL[1,2-a]PIRIMIDIN-3-ILMETIL]-AMINA, ENTRE OTROS. TAMBIEN SE REFIERE A COMPUESTOS DE FORMULA WHH Y A PROCEDIMIENTOS PARA LA PREPARACION. LOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DEL FACTOR DE LIBERACION DE CORTICOTROPINA Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE DEPRESION, ANSIEDAD, DESORDENES AFECTIVOS, DESORDENES DE TENSION POST-TRAUMATICA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26457001P | 2001-01-26 | 2001-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020844A1 true PE20020844A1 (es) | 2002-09-27 |
Family
ID=23006646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000063A PE20020844A1 (es) | 2001-01-26 | 2002-01-25 | Derivados de imidazolilo como inhibidores del factor de liberacion de la corticotropina |
Country Status (22)
| Country | Link |
|---|---|
| US (5) | US6888004B2 (es) |
| EP (1) | EP1359916A4 (es) |
| JP (1) | JP2004531475A (es) |
| KR (1) | KR20040034594A (es) |
| CN (1) | CN1499972A (es) |
| BG (1) | BG107999A (es) |
| BR (1) | BR0206698A (es) |
| CA (1) | CA2434558A1 (es) |
| CZ (1) | CZ20032044A3 (es) |
| EE (1) | EE200300342A (es) |
| HR (1) | HRP20030675A2 (es) |
| HU (1) | HUP0303721A2 (es) |
| IL (1) | IL156813A0 (es) |
| IS (1) | IS6889A (es) |
| MX (1) | MXPA03006484A (es) |
| NO (1) | NO20033350L (es) |
| PE (1) | PE20020844A1 (es) |
| PL (1) | PL368555A1 (es) |
| RU (1) | RU2003126188A (es) |
| SK (1) | SK9222003A3 (es) |
| WO (1) | WO2002058704A1 (es) |
| ZA (1) | ZA200305531B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002058704A1 (en) * | 2001-01-26 | 2002-08-01 | Bristol-Myers Squibb Company | Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
| CA2443802C (en) | 2001-04-27 | 2010-04-13 | Eisai Co., Ltd. | Pyrazolo[1,5-a]pyridines and medicines containing the same |
| CA2494574C (en) | 2002-10-22 | 2011-05-17 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
| US7176216B2 (en) | 2002-10-22 | 2007-02-13 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
| WO2006065793A2 (en) * | 2004-12-13 | 2006-06-22 | Indevus Pharmaceuticals, Inc. | TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR,10aR)-Δ8-TETRAHYDROCANNABINOL-11-OIC ACIDS |
| US7815905B2 (en) * | 2006-01-27 | 2010-10-19 | Research Development Foundation | Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitors |
| US9555032B2 (en) * | 2007-06-13 | 2017-01-31 | Research Development Foundation | Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling |
| AU2008329909B2 (en) * | 2007-11-29 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3- carboxylic acid amides |
| ES2396126T3 (es) | 2008-04-15 | 2013-02-19 | Eisai R&D Management Co., Ltd. | Compuesto de 3-fenilpirazol[5,1-b]tiazol |
| US7994203B2 (en) * | 2008-08-06 | 2011-08-09 | Novartis Ag | Organic compounds |
| AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
| CN102762572A (zh) * | 2010-02-01 | 2012-10-31 | 诺瓦提斯公司 | 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物 |
| US9806270B2 (en) | 2011-03-25 | 2017-10-31 | Udc Ireland Limited | 4H-imidazo[1,2-a]imidazoles for electronic applications |
| EP3034508B1 (en) * | 2011-03-25 | 2019-12-04 | UDC Ireland Limited | 4h-imidazo[1,2-a]imidazoles for electronic applications |
| EP2776443B1 (en) | 2011-11-10 | 2016-02-03 | Basf Se | 4h-imidazo[1,2-a]imidazoles for electronic applications |
| EP2812310A1 (de) * | 2012-02-07 | 2014-12-17 | Bayer Intellectual Property GmbH | Verfahren zur herstellung von substituierten anthranilsäure-derivaten |
| BR112014029295B1 (pt) | 2012-05-25 | 2021-04-27 | Nutech Ventures | Ciclobutenos e ciclobutanos anfifílicos e composição farmacêutica que os compreende |
| JP6231561B2 (ja) | 2012-07-10 | 2017-11-15 | ユー・ディー・シー アイルランド リミテッド | 電子用途のためのベンズイミダゾ［１，２−ａ］ベンズイミダゾール誘導体 |
| WO2014015167A2 (en) * | 2012-07-18 | 2014-01-23 | University Of Notre Dame Du Lac | 5,5-heteroaromatic anti-infective compounds |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| CN105384691B (zh) * | 2015-10-26 | 2018-06-29 | 深圳大学 | 一种谷氨酰胺酰基环化酶抑制剂的制备方法及应用 |
| US11214550B2 (en) | 2017-07-24 | 2022-01-04 | University Of South Florida | Bis-cyclic guanidines as antibacterial agents |
| US10729693B2 (en) * | 2018-03-02 | 2020-08-04 | Ponce Medical School Foundation, Inc. | Compositions and methods for the treatment of endometriosis |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3865836A (en) * | 1972-12-08 | 1975-02-11 | Janssen Pharmaceutica Nv | Bicyclic imidazoles |
| DE2827617A1 (de) * | 1978-06-23 | 1980-01-10 | Boehringer Sohn Ingelheim | Neue imidazo eckige klammer auf 1,2- alpha eckige klammer zu imidazole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung |
| IL69417A (en) * | 1982-08-27 | 1987-12-20 | Roussel Uclaf | 2-acyl imidazo(1,2-a)pyrimidines,their preparation and pharmaceutical compositions containing them |
| US4551530A (en) * | 1984-11-19 | 1985-11-05 | American Cyanamid Company | Pyridyl imidazo[1,2-a]pyrimidines |
| DK155524C (da) * | 1987-03-18 | 1989-09-11 | Ferrosan As | Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse |
| JPH05107705A (ja) * | 1991-10-17 | 1993-04-30 | Konica Corp | 新規な写真用カプラー |
| DE69321875T2 (de) * | 1992-05-19 | 1999-06-17 | Adir Et Compagnie, Courbevoie | Benzimidezolderivate mit antidiabetischer und Anti-Plättchenklumpungswirkung |
| EP0607076A1 (fr) * | 1993-01-15 | 1994-07-20 | Synthelabo | Dérivés de 9h-imidazo 1,2-a benzimidazole-3-acétamide à activité GABA |
| FR2722501B1 (fr) * | 1994-07-13 | 1996-08-09 | Synthelabo | Derives de 9h-imidazo(1,2-a)benzimidazole-3-acetamide, leur preparation et leur application en therapeutique |
| ATE243697T1 (de) | 1995-12-08 | 2003-07-15 | Pfizer | Substitutierte heterozyclische derivate als crf antagonisten |
| PL191271B1 (pl) * | 1996-02-07 | 2006-04-28 | Neurocrine Biosciences Inc | Pochodna pirazolopirymidyny i jej zastosowanie oraz kompozycja farmaceutyczna |
| US6022978A (en) | 1996-06-11 | 2000-02-08 | Pfizer Inc. | Benzimidazole derivatives |
| AU4398597A (en) * | 1996-10-03 | 1998-04-24 | Nissan Chemical Industries Ltd. | Heterocycle-fused pyrimidinone derivatives and herbicides |
| CA2281525A1 (en) | 1997-02-18 | 1998-08-20 | Neurocrine Biosciences, Inc. | Biazacyclic crf antagonists |
| EP0994877A1 (en) | 1997-07-03 | 2000-04-26 | Du Pont Pharmaceuticals Company | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| AU9021598A (en) | 1997-08-22 | 1999-03-16 | Du Pont Pharmaceuticals Company | Nitrogen substituted imidazo{4,5-c}pyrazoles as corticotropin relea sing hormone antagonists |
| BR9803368A (pt) | 1997-09-05 | 2001-04-24 | Sumitomo Chemical Co | Derivados de perimidona e herbecidas contendo os mesmos |
| AU1520699A (en) * | 1997-11-07 | 1999-05-31 | Johns Hopkins University, The | Methods for treatment of disorders of cardiac contractility |
| AU1687199A (en) * | 1997-12-26 | 1999-07-19 | Takeda Chemical Industries Ltd. | Nitrogen-containing heterocyclic compounds, their production and use |
| US6509338B1 (en) | 1998-06-22 | 2003-01-21 | Bristol-Myers Squibb Company | Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists |
| US6124463A (en) | 1998-07-02 | 2000-09-26 | Dupont Pharmaceuticals | Benzimidazoles as corticotropin release factor antagonists |
| US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
| US6271380B1 (en) | 1998-12-30 | 2001-08-07 | Dupont Pharmaceuticals Company | 1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands |
| WO2000059907A2 (en) | 1999-04-06 | 2000-10-12 | Du Pont Pharmaceuticals Company | Pyrazolotriazines as crf antagonists |
| AU4203500A (en) | 1999-04-06 | 2000-10-23 | Du Pont Pharmaceuticals Company | Pyrazolopyrimidines as crf antagonists |
| US6492408B1 (en) * | 1999-07-21 | 2002-12-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
| EP1309595A2 (en) * | 2000-08-09 | 2003-05-14 | Boehringer Ingelheim Pharmaceuticals Inc. | Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo(1,2-a) imidazol-2-one |
| US6696441B1 (en) * | 2000-08-11 | 2004-02-24 | The Regents Of The University Of California | Inhibition of p53-induced stress response |
| HUP0303038A2 (hu) * | 2000-09-21 | 2003-12-29 | Bristol-Myers Squibb Co. | Szubsztituált azolszármazékok mint kortikotropin releasing faktor inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| WO2002058704A1 (en) * | 2001-01-26 | 2002-08-01 | Bristol-Myers Squibb Company | Imidazolyl derivatives as corticotropin releasing factor inhibitors |
-
2002
- 2002-01-11 WO PCT/US2002/000841 patent/WO2002058704A1/en not_active Ceased
- 2002-01-11 IL IL15681302A patent/IL156813A0/xx unknown
- 2002-01-11 US US10/044,183 patent/US6888004B2/en not_active Expired - Lifetime
- 2002-01-11 EE EEP200300342A patent/EE200300342A/xx unknown
- 2002-01-11 RU RU2003126188/04A patent/RU2003126188A/ru not_active Application Discontinuation
- 2002-01-11 EP EP02705754A patent/EP1359916A4/en not_active Withdrawn
- 2002-01-11 CN CNA028071352A patent/CN1499972A/zh active Pending
- 2002-01-11 KR KR10-2003-7009883A patent/KR20040034594A/ko not_active Withdrawn
- 2002-01-11 CA CA002434558A patent/CA2434558A1/en not_active Abandoned
- 2002-01-11 BR BR0206698-0A patent/BR0206698A/pt not_active IP Right Cessation
- 2002-01-11 JP JP2002559038A patent/JP2004531475A/ja active Pending
- 2002-01-11 PL PL02368555A patent/PL368555A1/xx unknown
- 2002-01-11 MX MXPA03006484A patent/MXPA03006484A/es unknown
- 2002-01-11 HR HR20030675A patent/HRP20030675A2/hr not_active Application Discontinuation
- 2002-01-11 HU HU0303721A patent/HUP0303721A2/hu unknown
- 2002-01-11 CZ CZ20032044A patent/CZ20032044A3/cs unknown
- 2002-01-11 SK SK922-2003A patent/SK9222003A3/sk unknown
- 2002-01-25 PE PE2002000063A patent/PE20020844A1/es not_active Application Discontinuation
-
2003
- 2003-07-17 ZA ZA200305531A patent/ZA200305531B/en unknown
- 2003-07-17 BG BG107999A patent/BG107999A/xx unknown
- 2003-07-24 IS IS6889A patent/IS6889A/is unknown
- 2003-07-25 NO NO20033350A patent/NO20033350L/no not_active Application Discontinuation
-
2004
- 2004-01-29 US US10/767,645 patent/US7211669B2/en not_active Expired - Lifetime
- 2004-02-04 US US10/771,661 patent/US7125990B2/en not_active Expired - Lifetime
- 2004-02-04 US US10/771,766 patent/US7238699B2/en not_active Expired - Lifetime
- 2004-02-04 US US10/772,027 patent/US7244746B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1499972A (zh) | 2004-05-26 |
| US7244746B2 (en) | 2007-07-17 |
| EP1359916A1 (en) | 2003-11-12 |
| IS6889A (is) | 2003-07-24 |
| IL156813A0 (en) | 2004-02-08 |
| KR20040034594A (ko) | 2004-04-28 |
| US20040225130A1 (en) | 2004-11-11 |
| BR0206698A (pt) | 2004-04-20 |
| US20020183375A1 (en) | 2002-12-05 |
| US7238699B2 (en) | 2007-07-03 |
| CA2434558A1 (en) | 2002-08-01 |
| PL368555A1 (en) | 2005-04-04 |
| CZ20032044A3 (cs) | 2003-12-17 |
| SK9222003A3 (en) | 2004-05-04 |
| US20040235924A1 (en) | 2004-11-25 |
| BG107999A (en) | 2004-08-31 |
| US7125990B2 (en) | 2006-10-24 |
| ZA200305531B (en) | 2004-07-27 |
| HRP20030675A2 (en) | 2004-08-31 |
| RU2003126188A (ru) | 2005-03-27 |
| JP2004531475A (ja) | 2004-10-14 |
| HUP0303721A2 (hu) | 2004-03-01 |
| EP1359916A4 (en) | 2004-04-07 |
| US7211669B2 (en) | 2007-05-01 |
| US20040254382A1 (en) | 2004-12-16 |
| WO2002058704A1 (en) | 2002-08-01 |
| MXPA03006484A (es) | 2003-09-22 |
| NO20033350D0 (no) | 2003-07-25 |
| US6888004B2 (en) | 2005-05-03 |
| US20040225001A1 (en) | 2004-11-11 |
| EE200300342A (et) | 2003-12-15 |
| NO20033350L (no) | 2003-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020844A1 (es) | Derivados de imidazolilo como inhibidores del factor de liberacion de la corticotropina | |
| PE46899A1 (es) | Derivados de n-fenil-sulfonamida | |
| HUT74943A (en) | Pyrazino-pyrido-indole-derivatives, process of preparation and use as medicament, pharmaceutical compositions containing them and intermediates | |
| TR200401007T4 (tr) | Azabisiklik karbamatlar ve bunların, alfa-7 nikotinik asetilkolin reseptör agonistleri olarak kullanımları | |
| CY1108908T1 (el) | Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4 | |
| PE20020062A1 (es) | 5-AMINO-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PIRIMIDINA COMO ANTAGONISTAS RECEPTORES DE ADENOSINA A2a | |
| RU2009125578A (ru) | Новые замещенные диазаспиропиридиноновые производные для применения в лечении мсн-1-опосредованных заболеваний | |
| GT200000069A (es) | Derivados heterociclicos utiles como agentes anticancerosos. | |
| PE20021005A1 (es) | Quinazolinas como inhibidores de mmp-13 | |
| DK1355646T3 (da) | Muscariniske receptoragonister | |
| AR029423A1 (es) | Compuesto derivado de pirrolo-[pirimidin o piridin]-6-ona, metodo de preparacion de dichos compuestos, composiciones farmaceuticas que los comprenden, un metodo para regular, modular o inhibir la actividad de la proteina quinasa y un metodo de tratar o prevenir una enfermedad de mamiferos | |
| YU84791A (sh) | Biciklicni 1-aza-cikloalkalni | |
| CL2003002050A1 (es) | Compuestos derivados de 1-piperazin-1,2-dihidroindeno, su composicion farmaceutica y el uso de esta para tratar enfermedades del sistema nervioso central. | |
| MXPA02011417A (es) | 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos. | |
| DK377780A (da) | Fremgangsmaade til fremstilling af phenolderivater | |
| DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| DE60216745D1 (de) | Carbolin Derivate als Hemmstoffe von Phospphodiesterase 5 (PDE5) zur Behandlung kardiovaskulärer Erkrankungen und der erektilen Dysfunktion | |
| ATE420859T1 (de) | Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren | |
| GB9601680D0 (en) | Therapeutic agents | |
| YU64901A (sh) | Derivati bifenila | |
| DK0518767T3 (da) | Analoger af amidderivater af bestemte methanobroforbundne quinoliziner | |
| MX2007007115A (es) | Imidazo-benzodiazepinas tetraciclicas como moduladoras del receptor del acido gamma-aminobutirico (gaba). | |
| TR200200969T2 (tr) | Karbonilamino türevlerinin CNS bozukluklarına karşı kullanılması | |
| PE20011230A1 (es) | Derivados de imidazol como agonistas de alfa- 2- adrenoreceptores | |
| EA199900043A1 (ru) | ПРОИЗВОДНЫЕ ПИРИДИЛКАРБАМОИЛИНДОЛИНОВ В КАЧЕСТВЕ АНТАГОНИСТОВ 5-НТ2с-РЕЦЕПТОРОВ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |